|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 122, Issue 10 3151-3162, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
AR Hayman, SJ Jones, A Boyde, D Foster, WH Colledge, MB Carlton, MJ Evans and TM Cox
Department of Medicine, University of Cambridge, Addenbrooke's Hospital, UK.
Mature osteoclasts specifically express the purple, band 5 isozyme (Acp 5) of tartrate-resistant acid phosphatase, a binuclear metalloenzyme that can generate reactive oxygen species. The function of Acp 5 was investigated by targeted disruption of the gene in mice. Animals homozygous for the null Acp 5 allele had progressive foreshortening and deformity of the long bones and axial skeleton but apparently normal tooth eruption and skull plate development, indicating a role for Acp 5 in endochondral ossification. Histomorphometry and mineralization density analysis of backscattered electron imaging revealed widened and disorganized epiphyseal growth plates with delayed mineralization of cartilage in 6- to 8-week-old mutant mice. The membrane bones of the skull showed increased density at all ages examined, indicating defective osteoclastic bone turnover. Increased mineralization density was observed in the long bones of older animals which showed modelling deformities at their extremities: heterozygotes and homozygous Acp 5 mutant mice had tissue that was more mineralized and occupied a greater proportion of the bone in all regions. Thus the findings reflect a mild osteopetrosis due to an intrinsic defect of osteoclastic modelling activity that was confirmed in the resorption pit assay in vitro. We conclude that this bifunctional metalloprotein of the osteoclast is required for normal mineralization of cartilage in developing bones; it also maintains integrity and turnover of the adult skeleton by a critical contribution to bone matrix resorption.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Yu, J. L. Moreno, J. P. Stains, and A. D. Keegan Complex Regulation of Tartrate-resistant Acid Phosphatase (TRAP) Expression by Interleukin 4 (IL-4): IL-4 INDIRECTLY SUPPRESSES RECEPTOR ACTIVATOR OF NF-{kappa}B LIGAND (RANKL)-MEDIATED TRAP EXPRESSION BUT MODESTLY INDUCES ITS EXPRESSION DIRECTLY J. Biol. Chem., November 20, 2009; 284(47): 32968 - 32979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Campeau, M. Rafei, M.-N. Boivin, Y. Sun, G. A. Grabowski, and J. Galipeau Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome Blood, October 8, 2009; 114(15): 3181 - 3190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wu, L. H. Glimcher, and A. O. Aliprantis HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function PNAS, November 4, 2008; 105(44): 16934 - 16939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sun, D. E. Sleat, M. Lecocq, A. R. Hayman, M. Jadot, and P. Lobel Acid phosphatase 5 is responsible for removing the mannose 6-phosphate recognition marker from lysosomal proteins PNAS, October 28, 2008; 105(43): 16590 - 16595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kim, J. H. Kim, J. Lee, H.-M. Jin, S.-H. Lee, D. E. Fisher, H. Kook, K. K. Kim, Y. Choi, and N. Kim Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated Osteoclastogenesis J. Biol. Chem., October 21, 2005; 280(42): 35209 - 35216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Schwab, S. Granholm, E. Persson, B. Wilkes, U. H. Lerner, and H. H. Conaway Stimulation of Resorption in Cultured Mouse Calvarial Bones by Thiazolidinediones Endocrinology, October 1, 2005; 146(10): 4349 - 4361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ljusberg, Y. Wang, P. Lang, M. Norgard, R. Dodds, K. Hultenby, B. Ek-Rylander, and G. Andersson Proteolytic Excision of a Repressive Loop Domain in Tartrate-resistant Acid Phosphatase by Cathepsin K in Osteoclasts J. Biol. Chem., August 5, 2005; 280(31): 28370 - 28381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Mangashetti, S. M. Khapli, and M. R. Wani IL-4 Inhibits Bone-Resorbing Activity of Mature Osteoclasts by Affecting NF-{kappa}B and Ca2+ Signaling J. Immunol., July 15, 2005; 175(2): 917 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Alatalo, K. K. Ivaska, S. G. Waguespack, M. J. Econs, H. K. Vaananen, and J. M. Halleen Osteoclast-Derived Serum Tartrate-Resistant Acid Phosphatase 5b in Albers-Schonberg Disease (Type II Autosomal Dominant Osteopetrosis) Clin. Chem., May 1, 2004; 50(5): 883 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Tomscha, M. C. Trull, J. Deikman, J. P. Lynch, and M. J. Guiltinan Phosphatase Under-Producer Mutants Have Altered Phosphorus Relations Plant Physiology, May 1, 2004; 135(1): 334 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. J. van de Loo, M. B. Bennink, O. J. Arntz, R. L. Smeets, E. Lubberts, L. A. B. Joosten, P. L. E. M. van Lent, C. J. J. Coenen-de Roo, S. Cuzzocrea, B. H. Segal, et al. Deficiency of NADPH Oxidase Components p47phox and gp91phox Caused Granulomatous Synovitis and Increased Connective Tissue Destruction in Experimental Arthritis Models Am. J. Pathol., October 1, 2003; 163(4): 1525 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. So, J. Rho, D. Jeong, R. Park, D. E. Fisher, M. C. Ostrowski, Y. Choi, and N. Kim Microphthalmia Transcription Factor and PU.1 Synergistically Induce the Leukocyte Receptor Osteoclast-associated Receptor Gene Expression J. Biol. Chem., June 20, 2003; 278(26): 24209 - 24216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-J. Sheu, E. M. Schwarz, D. A. Martinez, R. J. O'Keefe, R. N. Rosier, M. J. Zuscik, and J. E. Puzas A Phage Display Technique Identifies a Novel Regulator of Cell Differentiation J. Biol. Chem., January 3, 2003; 278(1): 438 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Chellaiah, N. Kizer, R. Biswas, U. Alvarez, J. Strauss-Schoenberger, L. Rifas, S. R. Rittling, D. T. Denhardt, and K. A. Hruska Osteopontin Deficiency Produces Osteoclast Dysfunction Due to Reduced CD44 Surface Expression Mol. Biol. Cell, January 1, 2003; 14(1): 173 - 189. [Abstract] [Full Text]
|
|
|
|
|
|
B. Demiralp, H.-L. Chen, A. J. Koh, E. T. Keller, and L. K. McCauley Anabolic Actions of Parathyroid Hormone during Bone Growth Are Dependent on c-fos Endocrinology, October 1, 2002; 143(10): 4038 - 4047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Palmqvist, E. Persson, H. H. Conaway, and U. H. Lerner IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-{kappa}B Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvariae J. Immunol., September 15, 2002; 169(6): 3353 - 3362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, H. Zhu, K. Liu, X. Liu, G. Leggewie, M. Udvardi, and D. Wang Purple Acid Phosphatases of Arabidopsis thaliana. COMPARATIVE ANALYSIS AND DIFFERENTIAL REGULATION BY PHOSPHATE DEPRIVATION J. Biol. Chem., July 26, 2002; 277(31): 27772 - 27781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Waguespack, S. L. Hui, K. E. White, K. A. Buckwalter, and M. J. Econs Measurement of Tartrate-Resistant Acid Phosphatase and the Brain Isoenzyme of Creatine Kinase Accurately Diagnoses Type II Autosomal Dominant Osteopetrosis but Does Not Identify Gene Carriers J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2212 - 2217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Bull, P G Murray, D Thomas, A M Fraser, and P N Nelson Acid phosphatases Mol. Pathol., April 1, 2002; 55(2): 65 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Suter, V. Everts, A. Boyde, S. J. Jones, R. Lullmann-Rauch, D. Hartmann, A. R. Hayman, T. M. Cox, M. J. Evans, T. Meister, et al. Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice Development, December 1, 2001; 128(23): 4899 - 4910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sobacchi, A. Frattini, P. Orchard, O. Porras, I. Tezcan, M. Andolina, R. Babul-Hirji, I. Baric, N. Canham, D. Chitayat, et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis Hum. Mol. Genet., August 1, 2001; 10(17): 1767 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Hayman, P. Macary, P. J. Lehner, and T. M. Cox Tartrate-resistant Acid Phosphatase (Acp 5): Identification in Diverse Human Tissues and Dendritic Cells J. Histochem. Cytochem., June 1, 2001; 49(6): 675 - 684. [Abstract] [Full Text]
|
|
|
|
|
|
P. Lång, M. Schultzberg, and G. Andersson Expression and Distribution of Tartrate-resistant Purple Acid Phosphatase in the Rat Nervous System J. Histochem. Cytochem., March 1, 2001; 49(3): 379 - 396. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. C. Manolagas Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis Endocr. Rev., April 1, 2000; 21(2): 115 - 137. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Chellaiah, N. Kizer, M. Silva, U. Alvarez, D. Kwiatkowski, and K. A. Hruska Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength J. Cell Biol., February 21, 2000; 148(4): 665 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Hayman, A. J. Bune, J. R. Bradley, J. Rashbass, and T. M. Cox Osteoclastic Tartrate-resistant Acid Phosphatase (Acp 5): Its Localization to Dendritic Cells and Diverse Murine Tissues J. Histochem. Cytochem., February 1, 2000; 48(2): 219 - 228. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Vaananen, H Zhao, M Mulari, and J. Halleen The cell biology of osteoclast function J. Cell Sci., January 2, 2000; 113(3): 377 - 381. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Karsenty The genetic transformation of bone biology Genes & Dev., December 1, 1999; 13(23): 3037 - 3051. [Full Text]
|
|
|
|
|
|
J. M. Halleen, S. Raisanen, J. J. Salo, S. V. Reddy, G. D. Roodman, T. A. Hentunen, P. P. Lehenkari, H. Kaija, P. Vihko, and H. K. Vaananen Intracellular Fragmentation of Bone Resorption Products by Reactive Oxygen Species Generated by Osteoclastic Tartrate-resistant Acid Phosphatase J. Biol. Chem., August 13, 1999; 274(33): 22907 - 22910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schmidt, K. Lumniczky, B. D. Tzschaschel, H. L. Guenther, A. Luz, S. Riemann, W. Gimbel, V. Erfle, and R. G. Erben Onset and Dynamics of Osteosclerosis in Mice Induced by Reilly-Finkel-Biskis (RFB) Murine Leukemia Virus : Increase in Bone Mass Precedes Lymphomagenesis Am. J. Pathol., August 1, 1999; 155(2): 557 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Minkin and V.C. Marinho Role of the Osteoclast at the Bone-Implant Interface Advances in Dental Research, June 1, 1999; 13(1): 49 - 56. [Abstract] [PDF]
|
|
|
|
|
|
T. R. Kyriakides, Y.-H. Zhu, L. T. Smith, S. D. Bain, Z. Yang, M. T. Lin, K. G. Danielson, R. V. Iozzo, M. LaMarca, C. E. McKinney, et al. Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis J. Cell Biol., January 26, 1998; 140(2): 419 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Saftig, D. Hartmann, R. Lullmann-Rauch, J. Wolff, M. Evers, A. Koster, M. Hetman, K. von Figura, and C. Peters Mice Deficient in Lysosomal Acid Phosphatase Develop Lysosomal Storage in the Kidney and Central Nervous System J. Biol. Chem., July 25, 1997; 272(30): 18628 - 18635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Jansen, J. E. M. Groener, W. Bax, A. Suter, P. Saftig, P. Somerharju, and B. J. H. M. Poorthuis Biosynthesis of Phosphatidylcholine from a Phosphocholine Precursor Pool Derived from the Late Endosomal/Lysosomal Degradation of Sphingomyelin J. Biol. Chem., May 25, 2001; 276(22): 18722 - 18727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Matsumoto, K. Hisatake, Y. Nogi, and M. Tsujimoto Regulation of Receptor Activator of NF-kappa B Ligand-induced Tartrate-resistant Acid Phosphatase Gene Expression by PU.1-interacting Protein/Interferon Regulatory Factor-4. SYNERGISM WITH MICROPHTHALMIA TRANSCRIPTION FACTOR J. Biol. Chem., August 24, 2001; 276(35): 33086 - 33092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Luchin, S. Suchting, T. Merson, T. J. Rosol, D. A. Hume, A. I. Cassady, and M. C. Ostrowski Genetic and Physical Interactions between Microphthalmia Transcription Factor and PU.1 Are Necessary for Osteoclast Gene Expression and Differentiation J. Biol. Chem., September 21, 2001; 276(39): 36703 - 36710. [Abstract] [Full Text] [PDF]
|
|
